Two-pronged approach could curb many cases of lung cancer

Lung cancer, a leading killer, has been hard to target with drugs. A team took a metabolic approach, looking at what lung tumor cells need to live and grow. When they removed these factors, tumor growth was almost completely suppressed in a mouse model. Their findings suggest that a combination of existing drugs (IGF-1 inhibitors and inhibitors of protein breakdown) could provide an alternative to chemotherapy in curbing this deadly cancer. (Mehr in: Cancer News — ScienceDaily)